NICCOLAI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 6.973
EU - Europa 5.456
AS - Asia 4.269
SA - Sud America 503
Continente sconosciuto - Info sul continente non disponibili 278
AF - Africa 109
OC - Oceania 59
Totale 17.647
Nazione #
US - Stati Uniti d'America 6.814
RU - Federazione Russa 1.525
IT - Italia 1.313
CN - Cina 1.185
PL - Polonia 1.184
SG - Singapore 1.171
HK - Hong Kong 584
BR - Brasile 404
KR - Corea 366
VN - Vietnam 346
IE - Irlanda 307
SE - Svezia 222
FR - Francia 207
FI - Finlandia 204
DE - Germania 156
IN - India 145
GB - Regno Unito 113
BD - Bangladesh 104
CA - Canada 101
ID - Indonesia 77
NL - Olanda 69
AU - Australia 59
JO - Giordania 59
JP - Giappone 48
ES - Italia 46
TR - Turchia 35
MX - Messico 29
AR - Argentina 27
IQ - Iraq 22
ZA - Sudafrica 22
EC - Ecuador 19
UA - Ucraina 17
CI - Costa d'Avorio 16
CO - Colombia 16
PK - Pakistan 16
CH - Svizzera 15
NG - Nigeria 15
AT - Austria 14
LT - Lituania 13
VE - Venezuela 13
BE - Belgio 12
PH - Filippine 12
SA - Arabia Saudita 11
TW - Taiwan 11
EG - Egitto 10
IR - Iran 10
CL - Cile 9
UZ - Uzbekistan 9
MA - Marocco 8
PY - Paraguay 8
TN - Tunisia 8
CZ - Repubblica Ceca 7
KZ - Kazakistan 7
LB - Libano 7
NP - Nepal 7
BJ - Benin 6
DK - Danimarca 6
DZ - Algeria 6
HN - Honduras 6
KG - Kirghizistan 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
IL - Israele 5
JM - Giamaica 5
MY - Malesia 5
UG - Uganda 5
DO - Repubblica Dominicana 4
PE - Perù 4
PT - Portogallo 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
GH - Ghana 3
OM - Oman 3
AM - Armenia 2
AZ - Azerbaigian 2
EE - Estonia 2
ET - Etiopia 2
ML - Mali 2
NO - Norvegia 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
BO - Bolivia 1
BW - Botswana 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 17.357
Città #
Santa Clara 1.194
Warsaw 1.182
Ashburn 999
Singapore 875
Hong Kong 529
Fairfield 449
Hefei 364
Seoul 362
San Jose 313
Dublin 303
Chandler 265
Council Bluffs 219
Florence 213
Seattle 213
Beijing 197
Woodbridge 192
Houston 187
Milan 179
Cambridge 173
Los Angeles 151
Wilmington 129
Ho Chi Minh City 115
Helsinki 113
Lawrence 108
Altamura 106
Lauterbourg 104
Rome 104
The Dalles 95
Ann Arbor 93
Buffalo 91
Munich 90
New York 86
Dallas 85
Princeton 82
Hanoi 70
Chicago 69
Jakarta 58
Mumbai 55
Boston 52
Melbourne 52
Kent 51
Moscow 49
San Diego 46
Paris 43
Tokyo 42
Boardman 36
Bologna 33
Shanghai 33
São Paulo 32
Lappeenranta 31
Dong Ket 30
Medford 29
Toronto 29
Clifton 28
Orem 28
Salt Lake City 25
Frankfurt am Main 24
Turin 24
Bengaluru 23
London 23
Turku 23
Guangzhou 22
Genoa 19
Phoenix 19
Redondo Beach 19
Naples 17
Abidjan 16
West Jordan 16
Brooklyn 15
Da Nang 15
Denver 15
Hillsboro 15
Montreal 15
Abuja 14
Atlanta 14
Fiesole 14
Haiphong 14
Johannesburg 14
Bari 13
Bern 13
Elk Grove Village 12
Figino 12
Manchester 12
Pune 12
Tampa 12
Yubileyny 12
Amsterdam 11
Chennai 11
Rio de Janeiro 11
Vienna 11
Baghdad 10
Jacksonville 10
San Francisco 10
Brussels 9
Cairo 9
Detroit 9
Pescara 9
Stockholm 9
Barcelona 8
Bogotá 8
Totale 11.504
Nome #
Preliminary comparison of oral and intestinal human microbiota in patients with colorectal cancer: a pilot study 404
Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma. 361
Intra-tumoral IFN-gamma-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer 286
Evaluation and comparison of short chain fatty acids composition in gut diseases 276
The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course 274
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer 268
Studio della risposta T immuno-specifica in corso di tumori dell'apparato digerente 262
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 259
Visceral sensitivity modulation by faecal microbiota transplantation: the active role of gut bacteria in pain persistence 258
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG study 257
Potential Role of M. tuberculosis Specific IFN-γ and IL-2 ELISPOT Assays in Discriminating Children with Active or Latent Tuberculosis 252
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy. 238
Nourishing Immunity and Combatting Neuroinflammation: The Power of Immunonutrition and The Microbiome 234
Gastric cancer and the epoch of immunotherapy approaches 234
The gut–brain axis in the neuropsychological disease model of obesity: A classical movie revised by the emerging director “microbiome” 234
Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia 232
T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology. 229
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 227
The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer 220
The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit 216
Thrombosis in vasculitis: from pathogenesis to treatment 214
Broad targeting of angiogenesis for cancer prevention and therapy 211
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 207
A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer 205
Breast cancer: the first comparative evaluation of oncobiome composition between males and females 204
A MULTI-DISEASE STATISTICAL ANALYSIS OF FREE FATTY ACID SIGNATURES ASSESSED BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY 204
Designing a broad-spectrum integrative approach for cancer prevention and treatment 199
Characterization of the "gut microbiota-immunity axis" and microbial lipid metabolites in atrophic and potential celiac disease 197
Broad targeting of resistance to apoptosis in cancer 196
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets 195
Tissue invasion and metastasis: Molecular, biological and clinical perspectives 193
Fecal metabolomic profiles: A comparative study of patients with colorectal cancer vs adenomatous polyps 193
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 190
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 190
Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes 188
Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function 185
Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma 183
Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome 181
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 180
A multi-targeted approach to suppress tumor-promoting inflammation 179
Free fatty acids signature in human intestinal disorders: Significant association between butyric acid and celiac disease 176
Moraxella catarrhalis-specific Th1 cells in BAL fluids of chronic obstructive pulmonary disease patients. 174
Cancer prevention and therapy through the modulation of the tumor microenvironment 174
Circulating miRNome profiling data in Behçet's syndrome 174
Immune landscape and oncobiota in HPV-Associated Colorectal Cancer: an explorative study 173
Diving into Inflammation: A Pilot Study Exploring the Dynamics of the Immune-Microbiota Axis in Ileal Tissue Layers of Patients with Crohn's Disease 172
Differential Diagnosis 171
Adverse Effects of Micro- and Nanoplastics on Humans and the Environment 170
Alterations of circulating free fatty acids in patients with pemphigus vulgaris 167
Exploring Plasma-Level Gut Microbiota Mediators and Pro-Inflammatory Markers in Pregnant Women with Short Cervix and Gestational Diabetes Mellitus 165
Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA) 163
Intratumour microbiota modulates adrenocortical cancer responsiveness to mitotane 161
Machine learning for analysis of gene expression data in fast- and slow-progressing amyotrophic lateral sclerosis murine models 160
Microparticles: Bridging the gap between autoimmunity and thrombosis 158
The first taxonomic and functional characterization of human CAVD-associated microbiota 156
Host genetics and gut microbiota influence lipid metabolism and inflammation: potential implications for ALS pathophysiology in SOD1G93A mice 156
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds 156
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition 155
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules 154
Novel immunotherapeutic strategies of gastric cancer treatment 153
Assessing the Impact of Polyethylene Nano/Microplastic Exposure on Human Vaginal Keratinocytes 152
Utilization of formalin-fixed paraffin-embedded specimens for microbiota characterization in cancer: utility and concern 151
MICROBIOTA-INFLAMMATION-BRAIN AXIS IN HEART FAILURE: NEW FOOD, BIOMARKERS AND AI APPROACH FOR THE PREVENTION OF UNDERNUTRITION IN OLDER-AMBROSIA 151
The Future Exploring of Gut Microbiome-Immunity Interactions: From In Vivo/Vitro Models to In Silico Innovations 148
The gut microbiota-immunity axis in als: A role in deciphering disease heterogeneity? 147
Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma 146
Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma 145
HELICOBACTER PYLORI HP0175 PROMOTES THE PRODUCTION OF IL-23, IL-6, IL-1 beta AND TGF-beta 145
What is recent in pancreatic cancer immunotherapy? 144
Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions. 144
Gastritis in Helicobacter pylori infection 143
Experimental tests challenge the evidence of a healthy human blood microbiome 140
Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis: Clinical Protocol and Evaluation of Microbiota Immunity Axis 140
Rummeliibacillus suwonensis: First Time Isolation from Human Feces by Culturomics 140
Pancreatic cancer: Role of the immune system in cancer progression and vaccine-based immunotherapy 140
T cells, tissue factor and malignancy 139
Gut-lung microbiota dynamics in mice exposed to Nanoplastics 136
GLP-2 Prevents Neuronal and Glial Changes in the Distal Colon of Mice Chronically Treated with Cisplatin 134
Therapeutic targeting of replicative immortality 134
Synergistic Strategies for Gastrointestinal Cancer Care: Unveiling the Benefits of Immunonutrition and Microbiota Modulation 131
Role of immune response in yersinia pestis infection. 130
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile 128
Cytokine and microbiota profiles in obesity-related hypertension patients 127
Skin CD30(+) T cells and circulating levels of soluble CD30 are increased in patients with graft versus host disease 124
Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies 123
Nutritional and Microbiota-Based Approaches in Amyotrophic Lateral Sclerosis: From Prevention to Treatment 117
Familial Hypercholesterolemia and Acute Coronary Syndromes: The Microbiota–Immunity Axis in the New Diagnostic and Prognostic Frontiers 116
TDP-43-immunity-microbiota axis in amyotrophic lateral sclerosis: A potential pathogenic mechanism 110
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 108
Probiotics as adjuvants to mitigate adverse reactions and enhance effectiveness in Food Allergy Immunotherapy 101
Rheumatic diseases: The microbiota-immunity axis in development and treatment 97
Six-Month Synbio® Administration Affects Nutritional and Inflammatory Parameters of Older Adults Included in the PROBIOSENIOR Project 94
Duplication of exons 15 and 16 in Matrin-3: a phenotype bridging amyotrophic lateral sclerosis and immune-mediated disorders 92
Plant and Marine Sources: Biological Activity of Natural products and therapeutic Use 91
Th17 Cells in Multiple Sclerosis Express Higher Levels of JAK2, Which Increases Their Surface Expression of IFN-γR2 90
Gastrointestinal Status and Microbiota Shaping in Amyotrophic Lateral Sclerosis: A New Frontier for Targeting? 90
Dysregulated metabolism contributes to oncogenesis 85
Potential Association of the Oral Microbiome with Trimethylamine N-Oxide Quantification in Mexican Patients with Myocardial Infarction 81
Specific Intratumoral Microbiome Signatures in Human Glioblastoma and Meningioma: Evidence for a Gut–Brain Microbial Axis 49
Analysis of Microbiome for AP and CRC Discrimination 47
Totale 17.253
Categoria #
all - tutte 50.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.153


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022469 0 22 75 25 4 22 14 66 17 18 62 144
2022/20231.335 120 317 70 73 74 202 183 71 134 21 31 39
2023/2024690 19 56 107 36 42 112 33 124 11 69 29 52
2024/20254.767 132 442 291 692 1.127 534 166 305 210 194 320 354
2025/20266.945 771 895 753 604 687 282 758 323 511 428 258 675
2026/2027419 258 161 0 0 0 0 0 0 0 0 0 0
Totale 17.647